Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Pharmacology in Drug Development|December 23, 2022
Evaluation of Ethnicity Effect on Intranasal Esketamine Pharmacokinetics by Population Pharmacokinetic Modeling Using Data From a Japanese Phase 2b StudyKen Kurosawa, Minaka Shibuya, Hiroko Shimizu, et al.
The AAPS Journal|March 16, 2019
A Receiver Operating Characteristic Framework for Non-adherence Detection Using Drug Concentration Thresholds-Application to Simulated Risperidone Data in Schizophrenic PatientsCarlos Pérez-Ruixo, Bart Remmerie, Juan José Peréz-Ruixo, et al.
Clinical Pharmacokinetics|April 6, 2023
Pharmacodynamic-Mediated Drug Disposition (PDMDD) Model of Daratumumab Monotherapy in Patients with Multiple MyelomaXia Li, Anne-Gaëlle Dosne, Carlos Pérez Ruixo, et al.
Clinical Pharmacology and Therapeutics|December 23, 2025
Mechanistic Population Pharmacokinetic-Pharmacodynamic Model of the Tau-Targeted Antibody Posdinemab in Healthy Participants and Participants with Alzheimer's DiseaseCarlos Pérez-Ruixo, Lingjue Li, Wendy R Galpern, et al.
The AAPS Journal|June 8, 2021
Population Pharmacokinetic Analysis of Darunavir and Tenofovir Alafenamide in HIV-1-Infected Patients on the Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen (AMBER and EMERALD Studies)Oliver Ackaert, David McDougall, Carlos Pérez-Ruixo, et al.
Clinical Pharmacokinetics|August 22, 2019
Population Pharmacokinetics of Apalutamide and its Active Metabolite N-Desmethyl-Apalutamide in Healthy and Castration-Resistant Prostate Cancer SubjectsCarlos Pérez-Ruixo, Jonás Samuel Pérez-Blanco, Caly Chien, et al.
The AAPS Journal|November 19, 2015
Platelet Dynamics in Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal OxaliplatinCarlos Pérez-Ruixo, Belén Valenzuela, José Esteban Peris, et al.
Clinical Pharmacokinetics|July 6, 2013
Neutrophil dynamics in peritoneal carcinomatosis patients treated with cytoreductive surgery and hyperthermic intraperitoneal oxaliplatinCarlos Pérez-Ruixo, Belén Valenzuela, José Esteban Peris, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2014
Rate and extent of oxaliplatin absorption after hyperthermic intraperitoneal administration in peritoneal carcinomatosis patientsCarlos Pérez-Ruixo, José E Peris, Vanesa Escudero-Ortiz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 2013
Population pharmacokinetics of hyperthermic intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis after cytoreductive surgeryCarlos Pérez-Ruixo, Belén Valenzuela, José Esteban Peris, et al.
Pageof 2